Filing Details
- Accession Number:
- 0001209191-14-040981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-12 18:07:01
- Reporting Period:
- 2014-06-06
- Filing Date:
- 2014-06-12
- Accepted Time:
- 2014-06-12 17:07:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1428522 | Radius Health Inc. | RDUS | Blank Checks (6770) | 800145732 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 924223 | Ag Biotech Bb | Vordergasse 3 Schaffhausen V8 8200 | No | No | Yes | No | |
| 1259869 | V N Growth Biotech | Snipweg 26 Curacao 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-06 | 589,290 | $0.00 | 589,290 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-06-06 | 428,459 | $0.00 | 1,017,749 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-06-06 | 500,029 | $0.00 | 1,517,778 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-06-06 | 187,262 | $0.00 | 1,705,040 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2014-06-06 | 1,000,000 | $8.00 | 2,705,040 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | J | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Convertible Preferred Stock | Disposition | 2014-06-06 | 122,820 | $0.00 | 589,290 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2014-06-06 | 97,688 | $0.00 | 428,459 | $0.00 |
| Common Stock | Series B-2 Convertible Preferred Stock | Disposition | 2014-06-06 | 65,125 | $0.00 | 500,029 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V.
- The Series A-1 Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 4.798-for-1 basis upon the listing of the Issuer's Common Stock on a national securities exchange and had no expiration date. The Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 4.386-for-1 basis upon the listing of the Issuer's Common Stock on a national securities exchange and had no expiration date. The Series B-2 Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 7,678-for-1 basis upon the listing of the Issuer's Common Stock on a national securities exchange and had no expiration date.
- In connection with the listing of the Issuer's Common Stock on a national securities exchange, the Issuer issued shares of its Common Stock to certain of its preferred stock holders in satisfaction of accumulated and unpaid dividends.
Billionaire Hedge Funds
